$INFU
InfuSystem Holdings, Inc Stock $infu

$infu Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 10-Q Financial Statement

#000119312517339757 Filed on November 13, 2017

Income Statement

Concept	2017 Q4	2017 Q3	2016 Q3
Revenue	$18.89M	$17.59M	$17.23M
YoY Change	12.11%	2.1%	-5.93%
Cost Of Revenue	$6.460M	$4.452M	$4.018M
YoY Change	17.67%	10.8%	12.23%
Gross Profit	$12.44M	$11.04M	$10.39M
YoY Change	9.51%	6.28%	-19.32%
Gross Profit Margin	65.85%	62.78%	60.31%
Selling, General & Admin	$10.17M	$7.823M	$7.757M
YoY Change	3.25%	0.85%	-6.97%
% of Gross Profit	81.75%	70.85%	74.67%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.480M	$100.0K	$1.060M
YoY Change	-86.23%	-90.57%	960.0%
% of Gross Profit	11.9%	0.91%	10.2%
Operating Expenses	$11.64M	$10.48M	$9.813M
YoY Change	4.77%	6.81%	-6.96%
Operating Profit	$800.0K	$560.0K	$576.0K
YoY Change	220.0%	-2.78%	-75.28%
Interest Expense	-$320.0K	$354.0K	$384.0K
YoY Change	-3.03%	-7.81%	13.61%
% of Operating Profit	-40.0%	63.21%	66.67%
Other Income/Expense, Net	$0.00	-$362.0K	-$390.0K
YoY Change	-100.0%	-7.18%	1.3%
Pretax Income	-$1.630M	$198.0K	$186.0K
YoY Change	103.75%	6.45%	-90.44%
Income Tax	-$640.0K	$327.0K	$130.0K
% Of Pretax Income		165.15%	69.89%
Net Earnings	-$17.99M	-$129.0K	$56.00K
YoY Change	3727.66%	-330.36%	-95.08%
Net Earnings / Revenue	-95.24%	-0.73%	0.33%
Basic Earnings Per Share		-$0.01	$0.00
Diluted Earnings Per Share	-$789.7K	-$0.01	$0.00
COMMON SHARES
Basic Shares Outstanding	22.78M shares	22.76M	22.62M shares
Diluted Shares Outstanding		22.76M	23.00M shares

Balance Sheet

Concept	2017 Q4	2017 Q3	2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.500M	$800.0K	$1.100M
YoY Change	2.94%	-27.27%	10.0%
Cash & Equivalents	$3.469M	$803.0K	$1.072M
Short-Term Investments
Other Short-Term Assets	$1.150M	$1.121M	$1.260M
YoY Change	21.18%	-11.03%	52.91%
Inventory	$1.764M	$1.873M	$2.065M
Prepaid Expenses
Receivables	$11.28M	$10.97M	$12.22M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$17.67M	$14.77M	$19.36M
YoY Change	-14.94%	-23.7%	3.13%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.633M	$1.711M	$2.140M
YoY Change	-18.23%	-20.05%	-7.8%
Goodwill
YoY Change
Intangibles	$24.51M	$26.95M	$31.81M
YoY Change	-21.53%	-15.29%	3.54%
Long-Term Investments
YoY Change
Other Assets	$131.0K	$70.00K	$474.0K
YoY Change	-41.78%	-85.23%	110.67%
Total Long-Term Assets	$51.21M	$70.57M	$77.73M
YoY Change	-32.23%	-9.22%	4.29%
TOTAL ASSETS
Total Short-Term Assets	$17.67M	$14.77M	$19.36M
Total Long-Term Assets	$51.21M	$70.57M	$77.73M
Total Assets	$68.88M	$85.34M	$97.09M
YoY Change	-28.51%	-12.11%	4.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.516M	$4.093M	$4.676M
YoY Change	3.78%	-12.47%	-15.38%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$3.039M	$2.849M	$7.283M
YoY Change	-42.81%	-60.88%	38.3%
Total Short-Term Liabilities	$12.47M	$9.953M	$14.65M
YoY Change	-24.12%	-32.07%	-1.07%
LONG-TERM LIABILITIES
Long-Term Debt	$25.35M	$26.54M	$31.36M
YoY Change	-4.61%	-15.38%	4.63%
Other Long-Term Liabilities	$7.000K	$0.00	$100.0K
YoY Change	-89.39%	-100.0%
Total Long-Term Liabilities	$37.93M	$26.64M	$31.36M
YoY Change	29.82%	-15.05%	4.63%
TOTAL LIABILITIES
Total Short-Term Liabilities	$12.47M	$9.953M	$14.65M
Total Long-Term Liabilities	$37.93M	$26.64M	$31.36M
Total Liabilities	$37.93M	$36.59M	$46.11M
YoY Change	-16.92%	-20.65%	2.97%
SHAREHOLDERS EQUITY
Retained Earnings	-$61.63M	-$43.64M	-$40.67M
YoY Change	49.81%	7.3%	-4.18%
Common Stock	$2.000K	$2.000K	$2.000K
YoY Change	0.0%	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$30.95M	$48.75M	$50.98M
YoY Change
Total Liabilities & Shareholders Equity	$68.88M	$85.34M	$97.09M
YoY Change	-28.51%	-12.11%	4.06%

Cashflow Statement

Concept	2017 Q4	2017 Q3	2016 Q3
OPERATING ACTIVITIES
Net Income	-$17.99M	-$129.0K	$56.00K
YoY Change	3727.66%	-330.36%	-95.08%
Depreciation, Depletion And Amortization	$1.480M	$100.0K	$1.060M
YoY Change	-86.23%	-90.57%	960.0%
Cash From Operating Activities	$3.620M	$2.870M	$1.870M
YoY Change	-13.19%	53.48%	16.88%
INVESTING ACTIVITIES
Capital Expenditures	-$120.0K	-$940.0K	$190.0K
YoY Change	-93.33%	-594.74%	137.5%
Acquisitions
YoY Change
Other Investing Activities	$350.0K	$900.0K	$480.0K
YoY Change	-69.3%	87.5%	-134.53%
Cash From Investing Activities	$230.0K	-$40.00K	$670.0K
YoY Change	-135.38%	-105.97%	-151.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.180M	-2.110M	-2.270M
YoY Change	-0.84%	-7.05%	2422.22%
NET CHANGE
Cash From Operating Activities	3.620M	2.870M	1.870M
Cash From Investing Activities	230.0K	-40.00K	670.0K
Cash From Financing Activities	-1.180M	-2.110M	-2.270M
Net Change In Cash	2.670M	720.0K	270.0K
YoY Change	14.59%	166.67%	35.0%
FREE CASH FLOW
Cash From Operating Activities	$3.620M	$2.870M	$1.870M
Capital Expenditures	-$120.0K	-$940.0K	$190.0K
Free Cash Flow	$3.740M	$3.810M	$1.680M
YoY Change	-37.35%	126.79%	10.53%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017Q3	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	101000
CY2017Q3	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	700000
CY2017Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	22780738	shares
CY2016Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1072000
CY2017Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	6847000
CY2017Q3	us-gaap	Assets Current AssetsCurrent	14768000
CY2017Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	10971000
CY2017Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4426000
CY2017Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	92383000
CY2017Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	4093000
CY2017Q3	us-gaap	Assets Assets	85335000
CY2017Q3	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	584000
CY2017Q3	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	33000
CY2017Q3	us-gaap	Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments	685000
CY2017Q3	us-gaap	Capital Leases Future Minimum Payments Remainder Of Fiscal Year CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear	153000
CY2017Q3	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	0
CY2017Q3	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	0
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	803000
CY2017Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2017Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22780738	shares
CY2017Q3	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	15000
CY2017Q3	us-gaap	Capital Leases Of Lessee Contingent Rentals Basis Spread On Variable Rate CapitalLeasesOfLesseeContingentRentalsBasisSpreadOnVariableRate	0.035	pure
CY2017Q3	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	514000
CY2017Q3	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	0
CY2017Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22978398	shares
CY2017Q3	us-gaap	Common Stock Value CommonStockValue	2000
CY2017Q3	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0399	pure
CY2017Q3	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	16334000
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	4347000
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	5248000
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	3975000
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	4783000
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	5216000
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	1382000
CY2017Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	26951000
CY2017Q3	infu	Capital And Operating Leases Future Minimum Payments Due In Three Years CapitalAndOperatingLeasesFutureMinimumPaymentsDueInThreeYears	1256000
CY2017Q3	infu	Capital And Operating Leases Future Minimum Payments Due In Four Years CapitalAndOperatingLeasesFutureMinimumPaymentsDueInFourYears	419000
CY2017Q3	infu	Intangible Assets Accumulated Amortization IntangibleAssetsAccumulatedAmortization	26377000
CY2017Q3	infu	Capital And Operating Leases Future Minimum Payments Due In Five Years CapitalAndOperatingLeasesFutureMinimumPaymentsDueInFiveYears	181000
CY2017Q3	us-gaap	Inventory Net InventoryNet	1873000
CY2017Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	53328000
CY2017Q3	infu	Medical Equipment In Rental Service Net Of Accumulated Depreciation MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation	24301000
CY2017Q3	infu	Capital And Operating Leases Future Minimum Payments Due In Two Years CapitalAndOperatingLeasesFutureMinimumPaymentsDueInTwoYears	1838000
CY2017Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2017Q3	us-gaap	Preferred Stock Value PreferredStockValue
CY2017Q3	infu	Unamortized Value Of Debt Issuance Costs Principal In Year Four UnamortizedValueOfDebtIssuanceCostsPrincipalInYearFour	30000
CY2017Q3	infu	Unamortized Value Of Debt Issuance Costs Principal Remainder Of Fiscal Year UnamortizedValueOfDebtIssuanceCostsPrincipalRemainderOfFiscalYear	7000
CY2017Q3	us-gaap	Liabilities Liabilities	36589000
CY2017Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	85335000
CY2017Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	26636000
CY2017Q3	us-gaap	Liabilities Current LiabilitiesCurrent	9953000
CY2017Q3	us-gaap	Long Term Debt LongTermDebt	29384000
CY2017Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	2849000
CY2017Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	3037000
CY2017Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	3037000
CY2017Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	3037000
CY2017Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	571000
CY2017Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	19702000
CY2017Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	26535000
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	938000
CY2017Q3	us-gaap	Other Assets Current OtherAssetsCurrent	1121000
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	1223000
CY2017Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2427000
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	4416000
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	1324000
CY2017Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	70000
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	181000
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	419000
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	331000
CY2017Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2017Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1711000
CY2017Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6137000
CY2017Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-43639000
CY2017Q3	us-gaap	Stockholders Equity StockholdersEquity	48746000
CY2017Q3	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	127000
CY2017Q3	infu	Medical Equipment Held For Sale Or Rental MedicalEquipmentHeldForSaleOrRental	1200000
CY2017Q3	infu	Capital And Operating Leases Future Minimum Payments Due Thereafter CapitalAndOperatingLeasesFutureMinimumPaymentsDueThereafter	938000
CY2017Q3	infu	Medical Equipment Net MedicalEquipmentNet	25501000
CY2017Q3	infu	Accumulated Depreciation On Pump Equipment AccumulatedDepreciationOnPumpEquipment	5300000
CY2017Q3	infu	Capital And Operating Leases Future Minimum Payments Due CapitalAndOperatingLeasesFutureMinimumPaymentsDue	5116000
CY2017Q3	infu	Unamortized Value Of Debt Issuance Costs Principal In Year Five UnamortizedValueOfDebtIssuanceCostsPrincipalInYearFive	30000
CY2017Q3	infu	Unamortized Value Of Debt Issuance Costs Principal In Year Three UnamortizedValueOfDebtIssuanceCostsPrincipalInYearThree	30000
CY2017Q3	infu	Unamortized Value Of Debt Issuance Costs Principal In Year Two UnamortizedValueOfDebtIssuanceCostsPrincipalInYearTwo	30000
CY2017Q3	infu	Capital And Operating Leases Future Minimum Payments Remainder Of Fiscal Year CapitalAndOperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	484000
CY2017Q3	infu	Medical Equipment In Rental Services Accumulated Depreciation MedicalEquipmentInRentalServicesAccumulatedDepreciation	33861000
CY2017Q3	infu	Unamortized Debt Issuance Expense Current UnamortizedDebtIssuanceExpenseCurrent	28000
CY2017Q3	infu	Medical Equipment In Rental Services Gross MedicalEquipmentInRentalServicesGross	58681000
CY2017Q3	infu	Medical Equipment In Rental Services Reserve MedicalEquipmentInRentalServicesReserve	519000
CY2017Q3	infu	Unamortized Debt Issuance Expense Noncurrent UnamortizedDebtIssuanceExpenseNoncurrent	99000
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	818000
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4989000
CY2016Q4	us-gaap	Assets Current AssetsCurrent	20769000
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	11581000
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4118000
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	91829000
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5315000
CY2016Q4	us-gaap	Assets Assets	96344000
CY2016Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	2938000
CY2016Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	2573000
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3398000
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22669675	shares
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22867335	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	2000
CY2016Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	2675000
CY2016Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	12436000
CY2016Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	31239000
CY2016Q4	us-gaap	Inventory Net InventoryNet	2166000
CY2016Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	53438000
CY2016Q4	us-gaap	Liabilities Liabilities	45655000
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	96344000
CY2016Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	29216000
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	16439000
CY2016Q4	us-gaap	Long Term Debt LongTermDebt	31891000
CY2016Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	5314000
CY2016Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	26577000
CY2016Q4	us-gaap	Other Assets Current OtherAssetsCurrent	949000
CY2016Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2872000
CY2016Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	66000
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	225000
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1997000
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6115000
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-41142000
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	50689000
CY2016Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	109000
CY2016Q4	infu	Medical Equipment Held For Sale Or Rental MedicalEquipmentHeldForSaleOrRental	1642000
CY2016Q4	infu	Medical Equipment Net MedicalEquipmentNet	29678000
CY2016Q4	infu	Accumulated Depreciation On Pump Equipment AccumulatedDepreciationOnPumpEquipment	3900000
CY2016Q4	infu	Medical Equipment In Rental Service Net Of Accumulated Depreciation MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation	28036000
CY2016Q4	infu	Medical Equipment In Rental Services Accumulated Depreciation MedicalEquipmentInRentalServicesAccumulatedDepreciation	30447000
CY2016Q4	infu	Unamortized Debt Issuance Expense Current UnamortizedDebtIssuanceExpenseCurrent	22000
CY2016Q4	infu	Medical Equipment In Rental Services Gross MedicalEquipmentInRentalServicesGross	59034000
CY2016Q4	infu	Intangible Assets Accumulated Amortization IntangibleAssetsAccumulatedAmortization	22199000
CY2016Q4	infu	Medical Equipment In Rental Services Reserve MedicalEquipmentInRentalServicesReserve	551000
CY2016Q4	infu	Unamortized Debt Issuance Expense Noncurrent UnamortizedDebtIssuanceExpenseNoncurrent	87000
	dei	Amendment Flag AmendmentFlag	false
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4182000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-2595000
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	13612000
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	us-gaap	Depreciation Nonproduction DepreciationNonproduction	400000
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.252	pure
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	dei	Document Type DocumentType	10-Q
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
	dei	Document Period End Date DocumentPeriodEndDate	2017-09-30
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
	dei	Entity Registrant Name EntityRegistrantName	InfuSystem Holdings, Inc
	dei	Entity Central Index Key EntityCentralIndexKey	0001337013
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	us-gaap	Gross Profit GrossProfit	32031000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	18451000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3627000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-914000
	us-gaap	Interest Expense InterestExpense	1015000
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	689000
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	4102000
	us-gaap	Operating Expenses OperatingExpenses	34532000
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-7386000
	us-gaap	Net Income Loss NetIncomeLoss	-2713000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2501000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1126000
	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	45228000
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	700000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-111000
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	38000
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	27000
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	2829000
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	3518000
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	131000
	us-gaap	Proceeds From Repayments Of Debt ProceedsFromRepaymentsOfDebt	28317000
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	4456000
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	35769000
	us-gaap	Sales Revenue Net SalesRevenueNet	52184000
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	6956000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	7443000
	dei	Trading Symbol TradingSymbol	INFU
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22725806	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22725806	shares
	infu	Cost Of Revenues Pump Depreciation Sales And Disposals CostOfRevenuesPumpDepreciationSalesAndDisposals	6541000
	infu	Depreciation Expense Related To Medical Equipment DepreciationExpenseRelatedToMedicalEquipment	4800000
	infu	Pump Equipments Net PumpEquipmentsNet	14000000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2792000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	254000
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	12313000
	us-gaap	Depreciation Nonproduction DepreciationNonproduction	400000
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.423	pure
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
	us-gaap	Gross Profit GrossProfit	34089000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	18328000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	433000
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	445591	shares
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	183000
	us-gaap	Interest Expense InterestExpense	1016000
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-4686000
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	3735000
	us-gaap	Operating Expenses OperatingExpenses	32661000
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	1205000
	us-gaap	Net Income Loss NetIncomeLoss	250000
	us-gaap	Operating Income Loss OperatingIncomeLoss	1428000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-995000
	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	47370000
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	800000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	21000
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	50000
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	200000
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	6997000
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	2511000
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	125000
	us-gaap	Proceeds From Repayments Of Debt ProceedsFromRepaymentsOfDebt	45327000
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3912000
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	44197000
	us-gaap	Sales Revenue Net SalesRevenueNet	53643000
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	6273000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	7629000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23059794	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22614203	shares
	infu	Cost Of Revenues Pump Depreciation Sales And Disposals CostOfRevenuesPumpDepreciationSalesAndDisposals	7241000
CY2016Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1098000
CY2016Q3	infu	Cost Of Revenues Pump Depreciation Sales And Disposals CostOfRevenuesPumpDepreciationSalesAndDisposals	2819000
CY2016Q3	infu	Depreciation Expense Related To Medical Equipment DepreciationExpenseRelatedToMedicalEquipment	1600000
CY2017Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1384000
CY2017Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4452000
CY2017Q3	us-gaap	Depreciation Nonproduction DepreciationNonproduction	100000
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	infu	Depreciation Expense Related To Medical Equipment DepreciationExpenseRelatedToMedicalEquipment	4700000
CY2016	infu	Pump Equipments Net PumpEquipmentsNet	13900000
CY2017Q1	infu	Leverage Ratio LeverageRatio	2.96	pure
CY2016Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	958000
CY2016Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4018000
CY2016Q3	us-gaap	Depreciation Nonproduction DepreciationNonproduction	100000
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2016Q3	us-gaap	Gross Profit GrossProfit	10389000
CY2016Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5267000
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	186000
CY2016Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	375257	shares
CY2016Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	130000
CY2016Q3	us-gaap	Interest Expense InterestExpense	384000
CY2016Q3	us-gaap	Operating Expenses OperatingExpenses	9813000
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	56000
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	576000
CY2016Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-390000
CY2016Q3	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	14640000
CY2016Q3	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	300000
CY2016Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-6000
CY2016Q3	us-gaap	Sales Revenue Net SalesRevenueNet	17226000
CY2016Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	2586000
CY2016Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2490000
CY2016Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22995643	shares
CY2016Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22620386	shares
CY2017Q3	us-gaap	Gross Profit GrossProfit	11041000
CY2017Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5561000
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	198000
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	327000
CY2017Q3	us-gaap	Interest Expense InterestExpense	354000
CY2017Q3	us-gaap	Operating Expenses OperatingExpenses	10481000
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	-129000
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	560000
CY2017Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-362000
CY2017Q3	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	15322000
CY2017Q3	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	200000
CY2017Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-8000
CY2017Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1274000
CY2017Q3	us-gaap	Sales Revenue Net SalesRevenueNet	17588000
CY2017Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	2266000
CY2017Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2262000
CY2017Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22755976	shares
CY2017Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22755976	shares
CY2017Q3	infu	Cost Of Revenues Pump Depreciation Sales And Disposals CostOfRevenuesPumpDepreciationSalesAndDisposals	2095000
CY2017Q3	infu	Depreciation Expense Related To Medical Equipment DepreciationExpenseRelatedToMedicalEquipment	1700000

Files In Submission

Name	View Source	Status
0001193125-17-339757-index-headers.html	Edgar Link	pending
0001193125-17-339757-index.html	Edgar Link	pending
0001193125-17-339757.txt	Edgar Link	pending
0001193125-17-339757-xbrl.zip	Edgar Link	pending
d486354d10q.htm	Edgar Link	pending
d486354dex311.htm	Edgar Link	pending
d486354dex312.htm	Edgar Link	pending
d486354dex321.htm	Edgar Link	pending
d486354dex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
g486354sp02.jpg	Edgar Link	pending
infu-20170930.xml	Edgar Link	completed
infu-20170930.xsd	Edgar Link	pending
infu-20170930_cal.xml	Edgar Link	unprocessable
infu-20170930_def.xml	Edgar Link	unprocessable
infu-20170930_lab.xml	Edgar Link	unprocessable
infu-20170930_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$INFU
InfuSystem Holdings, Inc Stock $infu

2017 Q4 Form 10-Q Financial Statement

#000119312517339757 Filed on November 13, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INFU InfuSystem Holdings, Inc Stock $infu

2017 Q4 Form 10-Q Financial Statement

#000119312517339757 Filed on November 13, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INFU
InfuSystem Holdings, Inc Stock $infu